DK127086A - Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser - Google Patents
Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser Download PDFInfo
- Publication number
- DK127086A DK127086A DK127086A DK127086A DK127086A DK 127086 A DK127086 A DK 127086A DK 127086 A DK127086 A DK 127086A DK 127086 A DK127086 A DK 127086A DK 127086 A DK127086 A DK 127086A
- Authority
- DK
- Denmark
- Prior art keywords
- naphthyridones
- procedures
- substituted
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/716,003 US4596809A (en) | 1985-03-25 | 1985-03-25 | Substituted 1,8-naphthyridinones, useful as anti-allergic agents |
| US06/836,357 US4687774A (en) | 1986-03-10 | 1986-03-10 | Method for suppressing the immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK127086D0 DK127086D0 (da) | 1986-03-19 |
| DK127086A true DK127086A (da) | 1986-09-26 |
Family
ID=27109452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK127086A DK127086A (da) | 1985-03-25 | 1986-03-19 | Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0196024B1 (hu) |
| KR (1) | KR900004829B1 (hu) |
| AU (1) | AU579718B2 (hu) |
| DE (1) | DE3675671D1 (hu) |
| DK (1) | DK127086A (hu) |
| FI (1) | FI84828C (hu) |
| GR (1) | GR860757B (hu) |
| HU (1) | HU196074B (hu) |
| IL (1) | IL78230A0 (hu) |
| NO (1) | NO164657C (hu) |
| NZ (1) | NZ215562A (hu) |
| OA (1) | OA08271A (hu) |
| PT (1) | PT82257B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI88033C (fi) * | 1986-04-11 | 1993-03-25 | Schering Corp | Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklobuta-, cyklopenta- och 7,8,9,10-tetrahydrobenso/c//1,8/naftyridin-6-onderivat |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3368929D1 (de) * | 1982-04-26 | 1987-02-12 | Schering Corp | 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives |
| US4680298A (en) * | 1983-05-31 | 1987-07-14 | Schering Corporation | Tricyclic anti-allergy and use as anti-inflammatory agents |
| GR850211B (hu) * | 1984-02-02 | 1985-05-24 | Merck & Co Inc | |
| FI88033C (fi) * | 1986-04-11 | 1993-03-25 | Schering Corp | Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklobuta-, cyklopenta- och 7,8,9,10-tetrahydrobenso/c//1,8/naftyridin-6-onderivat |
-
1986
- 1986-03-19 DK DK127086A patent/DK127086A/da not_active Application Discontinuation
- 1986-03-21 DE DE8686103874T patent/DE3675671D1/de not_active Expired - Fee Related
- 1986-03-21 FI FI861194A patent/FI84828C/fi not_active IP Right Cessation
- 1986-03-21 NZ NZ215562A patent/NZ215562A/xx unknown
- 1986-03-21 GR GR860757A patent/GR860757B/el unknown
- 1986-03-21 AU AU55027/86A patent/AU579718B2/en not_active Ceased
- 1986-03-21 EP EP86103874A patent/EP0196024B1/en not_active Expired - Lifetime
- 1986-03-21 IL IL78230A patent/IL78230A0/xx unknown
- 1986-03-24 OA OA58819A patent/OA08271A/xx unknown
- 1986-03-24 PT PT82257A patent/PT82257B/pt not_active IP Right Cessation
- 1986-03-24 NO NO861178A patent/NO164657C/no unknown
- 1986-03-25 KR KR1019860002206A patent/KR900004829B1/ko not_active IP Right Cessation
- 1986-03-25 HU HU861230A patent/HU196074B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5502786A (en) | 1986-10-02 |
| KR900004829B1 (ko) | 1990-07-07 |
| PT82257B (pt) | 1988-07-29 |
| EP0196024A1 (en) | 1986-10-01 |
| PT82257A (en) | 1986-04-01 |
| FI84828B (fi) | 1991-10-15 |
| NO164657B (no) | 1990-07-23 |
| EP0196024B1 (en) | 1990-11-22 |
| FI861194A (fi) | 1986-09-26 |
| DK127086D0 (da) | 1986-03-19 |
| FI861194A0 (fi) | 1986-03-21 |
| OA08271A (fr) | 1987-10-30 |
| GR860757B (en) | 1986-07-28 |
| KR860007263A (ko) | 1986-10-10 |
| NZ215562A (en) | 1988-11-29 |
| NO164657C (no) | 1990-10-31 |
| HUT41797A (en) | 1987-05-28 |
| HU196074B (en) | 1988-09-28 |
| NO861178L (no) | 1986-09-26 |
| IL78230A0 (en) | 1986-07-31 |
| FI84828C (fi) | 1992-01-27 |
| DE3675671D1 (de) | 1991-01-03 |
| AU579718B2 (en) | 1988-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK573384D0 (da) | Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater | |
| DK110886D0 (da) | Hidtil ukendte sulfonylaminoforbindelser, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater, der indeholder forbindelserne | |
| DK165949C (da) | 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne | |
| DK488885D0 (da) | 9-amino-1,2,3,4-tetrahydroacridin-1-ol og beslaegtede forbindelser, enfremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
| DK213085D0 (da) | Aminotetralinderivater, laegemidler indeholdende disse og fremgangsmaade til forbindelsernes fremstilling | |
| DK362787D0 (da) | Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
| DK163923C (da) | 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser | |
| DK590185A (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK592685D0 (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK408186D0 (da) | Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne | |
| DK250387A (da) | Di- og tetrahydroisoquinolin-derivater, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne | |
| DK162221C (da) | Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne | |
| DK457787D0 (da) | Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
| DK488385D0 (da) | N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DK617684A (da) | 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser | |
| DK187989D0 (da) | Substituerede propanaminer, fremgangsmaade til fremstilling heraf og laegemidler indeholdende saadanne forbindelser | |
| DK209384A (da) | 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne | |
| DK93385D0 (da) | 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser | |
| DK605186D0 (da) | 16,17-acetalsubstituerede pregnan-21-ionsyrederivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser | |
| DK512185D0 (da) | 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser | |
| DK31385A (da) | Benzopyranderivater, kompositioner indeholdende disse forbindelser ogfremgangsmaade til forbindelsernes fremstilling | |
| DK127086D0 (da) | Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske konpositioner, der indeholder disse forbindelser | |
| DK365087A (da) | 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse | |
| KR860005809A (ko) | 3--1h-인다졸, 이의 제조방법 및 이들 화합물을 함유하는 약제학적 조성물 | |
| DK339285A (da) | Pyridinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |